Grifols (GIKLY) Dividends Paid - Common (2013 - 2019)
Grifols (GIKLY) posted Dividends Paid - Common of -$108.9 million for Q4 2019, down 168.65% quarter-over-quarter from $158.7 million in Q4 2018, and down 168.65% year-on-year from $158.7 million in Q4 2018.
Grifols (GIKLY) Dividends Paid - Common (2013 - 2019) Analysis & Trends
Grifols (GIKLY) has reported Dividends Paid - Common for 5 consecutive years, with -$108.9 million the latest figure, recorded in Q4 2019.
- Dividends Paid - Common for Q4 2019 came in at -$108.9 million, down 168.65% year-over-year; the trailing twelve-month figure through Dec 2019 was $496.0 million (up 25.0% YoY), and the FY2025 annual result was $149.0 million, up 13843.31% from the prior year.
- Dividends Paid - Common was -$108.9 million for Q4 2019 at Grifols, down from $158.7 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $334.1 million in Q4 2016 and troughed at -$208.2 million in Q3 2016.
- Average Dividends Paid - Common over 5 years is $69.8 million, with a median of $121.6 million recorded in 2015.
- Year-over-year, Dividends Paid - Common jumped 154.79% in 2016 and slumped 168.65% in 2019.
- Over 5 years, Dividends Paid - Common stood at $131.1 million in 2015, then surged by 154.79% to $334.1 million in 2016, then slumped by 66.42% to $112.2 million in 2017, then soared by 41.47% to $158.7 million in 2018, then plunged by 168.65% to -$108.9 million in 2019.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were -$108.9 million in Q4 2019, $158.7 million in Q4 2018, and $112.2 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -108.94 Mn |
| Dec 31, 2019 | -108.94 Mn |
| Dec 31, 2018 | 158.70 Mn |
| Dec 31, 2018 | 158.70 Mn |
| Dec 31, 2017 | 112.18 Mn |
| Dec 31, 2017 | 112.18 Mn |
| Dec 31, 2016 | 334.06 Mn |
| Dec 31, 2016 | 334.06 Mn |
| Sep 30, 2016 | -208.15 Mn |
| Sep 30, 2016 | -208.15 Mn |
| Dec 31, 2015 | 131.11 Mn |
| Dec 31, 2015 | 131.11 Mn |
| Dec 31, 2014 | -87.37 Mn |
| Dec 31, 2014 | -87.37 Mn |
| Sep 30, 2014 | 92.90 Mn |
| Sep 30, 2014 | 92.90 Mn |
| Dec 31, 2013 | -1,361.09 |
| Dec 31, 2013 | -1,361.09 |
| Sep 30, 2013 | 1,325.04 |
| Sep 30, 2013 | 1,325.04 |